scholarly journals Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands

2021 ◽  
Author(s):  
Florentien J. Hinsenveld ◽  
Joost L Boormans ◽  
Henk G van der Poel ◽  
Deric K E van der Schoot ◽  
André N Vis ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
The Netherlands ◽  
Radical Cystectomy ◽  
Invasive Bladder Cancer ◽  
Robot Assisted ◽  
Muscle Invasive Bladder Cancer ◽  
Term Survival ◽  
Open Radical Cystectomy ◽  
Muscle Invasive

Comparison of Initial Experiences of Robot-Assisted Radical Cystectomy with those of Laparoscopic for Bladder Cancer

2014 ◽  
Vol 9 (4) ◽  
pp. 322-326 ◽  
Author(s):  
Jun Teishima ◽  
Keisuke Hieda ◽  
Shogo Inoue ◽  
Keisuke Goto ◽  
Kenichiro Ikeda ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Radical Cystectomy ◽  
Initial Period ◽  
Invasive Bladder Cancer ◽  
Perioperative Outcomes ◽  
Robot Assisted ◽  
Muscle Invasive Bladder Cancer ◽  
Conversion To Open Surgery ◽  
Muscle Invasive

Objective The aim of the present study was to evaluate perioperative outcomes in initial experiences of robot-assisted laparoscopic radical cystectomy (RARC) in comparison with those of laparoscopic radical cystectomy (LRC) for muscle-invasive or high-risk non-muscle-invasive bladder cancer. Methods We performed RARC on six patients with muscle-invasive or high-risk non-muscle-invasive bladder cancer starting in October 2011. During the same period, another five patients underwent LRC. Perioperative outcomes in initial experiences of RARC were elucidated by comparing them with those of LRC. Results Robot-assisted procedures were completed in all cases without conversion to open surgery. The median time of pneumoperitoneum was 252 minutes, and the median blood loss was 340 mL. No severe complications were observed. Perioperative outcomes did not significantly differ between RARC and LRC. Although two cases of troubles in uretero-conduit anastomosis sites were observed after LRC, no patients experienced postoperative complication related to urinary diversion after RARC. Conclusions Our data indicate that RARC is an acceptable option even in the initial period, and it may become one of the most favorable procedures for treatment of muscle-invasive bladder cancer in the near future, although more tests and longer follow-ups are required to confirm its effectiveness and safety.

scholarly journals Robot-Assisted Radical Cystectomy with Intra-corporeal Neo-Bladder

2021 ◽  
Author(s):  
Víctor Enrique Corona-Montes ◽  
Eduardo Gonzalez-Cuenca ◽  
Laurent López ◽  
Juan Eduardo Sánchez-Núñez ◽  
Richard Gaston
Keyword(s):  
Bladder Cancer ◽  
Radical Cystectomy ◽  
Gold Standard ◽  
Invasive Bladder Cancer ◽  
Intraoperative Blood Loss ◽  
Robot Assisted ◽  
Muscle Invasive Bladder Cancer ◽  
Oncological Results ◽  
Muscle Invasive ◽  
Continent Urinary Reservoir

The purpose of this chapter is to provide a step-by-step description of the robot-assisted radical cystectomy with an intra-corporeal neo-bladder technique and a recent review of its outcomes. The procedure is also known as anterior pelvic exenteration or cysto-prostatectomy in the case of female or male respectively. Radical cystectomy (RC) is the gold standard treatment for muscle-invasive bladder cancer, but there are also several surgical indications for non-muscle-invasive bladder cancer. In the past years, minimally invasive surgery and the da Vinci system technology have played a major role in this procedure, with description of brand-new techniques and specific approaches for the creation of a continent urinary reservoir. The following chapter provides a detailed description of the robot-assisted radical cystectomy (RARC) with Y-shaped intra-corporeal bladder as well as a literary review of distinct perioperative, functional and oncological outcomes from the available RARC randomized controlled trials. Despite its high cost and complexity, the intra-corporeal technique has become widely popular around the world and is used more frequently each time. The described data in this chapter, demonstrates that morbidity can be reduced whilst simultaneously offer non-inferior oncological results and less intraoperative blood loss in contrast to the open RC approach.

Sign in / Sign up

Export Citation Format

Share Document